Login / Signup

Parallel evolution of vgsc mutations at domains IS6, IIS6 and IIIS6 in pyrethroid resistant Aedes aegypti from Mexico.

Karla Saavedra-RodriguezFarah Vera MaloofCorey L CampbellJulian Garcia-RejonAudrey LenhartRosa Patricia Penilla-NavarroAmerico RodriguezArturo Acero SandovalAdriana E FloresGustavo PonceSaul Lozano-FuentesWilliam C Black
Published in: Scientific reports (2018)
Aedes aegypti is the primary urban mosquito vector of viruses causing dengue, Zika and chikungunya fevers -for which vaccines and effective pharmaceuticals are still lacking. Current strategies to suppress arbovirus outbreaks include removal of larval-breeding sites and insecticide treatment of larval and adult populations. Insecticidal control of Ae. aegypti is challenging, due to a recent rapid global increase in knockdown-resistance (kdr) to pyrethroid insecticides. Widespread, heavy use of pyrethroid space-sprays has created an immense selection pressure for kdr, which is primarily under the control of the voltage-gated sodium channel gene (vgsc). To date, eleven replacements in vgsc have been discovered, published and shown to be associated with pyrethroid resistance to varying degrees. In Mexico, F1,534C and V1,016I have co-evolved in the last 16 years across Ae. aegypti populations. Recently, a novel replacement V410L was identified in Brazil and its effect on vgsc was confirmed by electrophysiology. Herein, we screened V410L in 25 Ae. aegypti historical collections from Mexico, the first heterozygote appeared in 2002 and frequencies have increased in the last 16 years alongside V1,016I and F1,534C. Knowledge of the specific vgsc replacements and their interaction to confer resistance is essential to predict and to develop strategies for resistance management.
Keyphrases
  • aedes aegypti
  • zika virus
  • dengue virus
  • healthcare
  • randomized controlled trial
  • dna methylation
  • systematic review
  • genome wide
  • genetic diversity
  • young adults
  • quantum dots
  • replacement therapy